** Shares of Healius HLS.AX fall as much as 6% to A$1.405,
their lowest level since June 17
** Stock currently down 3%, faces worst day since May 28, if
current losses hold
** Healthcare services provider downgrades FY24 guidance
** HLS sees underlying FY24 EBITDA between A$345 mln to
A$350 mln($232.93 mln) as compared to previous guidance of A$359
mln to A$369 mln
** Co downgrades underlying FY24 EBIT between A$60 mln to
A$65 mln from previous guidance of A$70 mln to A$80 mln
** Stock fallen 9.9% this year as of last close
($1 = 1.5026 Australian dollars)
(Reporting by Shivangi Lahiri in Bengaluru)
((shivangi.lahiri@thomsonreuters.com))